Objectives: We aimed (1) to construct a modified PROCAM risk algorithm, which incorporates BMI/waist circumference in a model for predicting coronary events; (2) to evaluate how accurate this and the previously established PROCAM risk algorithm predict coronary risk in individuals with metabolic syndrome. Design: Prospective Cardiovascular Münster (PROCAM) Study, a prospective study of men and women at work in the northwest of Germany. Subjects: A total of 7134 men aged 35-65 years at study entry. Measurements: On the basis of 404 major coronary events (defined as nonfatal MI and coronary deaths), which occurred within 10 years of follow-up, a modified PROCAM risk algorithm was constructed by incorporating BMI/waist circumference as fixed variable in a Cox proportional hazards model for predicting coronary events. The metabolic syndrome was defined according to the latest recommendations proposed by the NCEP-ATP III Panel. Results: Men who were classified as having the metabolic syndrome (n ¼ 2325, prevalence: 32.6%) were 2.59-fold more likely to experience a major coronary event within 10 years of follow-up than men not having the metabolic syndrome. In men with metabolic syndrome, the observed major coronary event rate of 9.6% corresponded well with their estimated global risk according to the modified BMI-based PROCAM risk algorithm (10.2%). Comparative calculations performed with the previously published fully adjusted PROCAM algorithm yielded very similar results. Conclusion: Both PROCAM algorithms provide very accurate means to ascertain coronary risk in male patients with metabolic syndrome.
Introduction
In western societies like the European Union or the United States, roughly every fifth adult man and every fifth adult woman is affected by cardiovascular disease. 1 Despite considerable progress over the past 10 years with respect to treatment of coronary heart disease, its prevention remains a major public health challenge. Benefits that came with the widespread introduction of effective cholesterol lowering drugs (that is, statins) and a better awareness concerning a healthy lifestyle are counteracted by the current epidemic of overweight and obesity in many parts of the world. 2 Excess body weight is a well-established component of the metabolic syndrome, which is an expanding health threat due to its tight association with diabetes, hypertension, dyslipidaemia and atherosclerosis. 3, 4 The metabolic syndrome accounts for 6-7% of all-cause mortality in the United States, and it may be expected that life expectancy will plateau or even decline in the United States and other western societies within the first half of this century as a consequence of rising incidence rates of obesity-related morbidity. 5 Two widely used clinical definitions of the metabolic syndrome have been proposed. The latest version of the definition developed by the NCEP-ATP III Panel 6 relies on the presence of at least three out of the following five simple criteria: (1) increased waist circumference with population-specific cutoff values, (2) Irrespective of which definition is used to diagnose the metabolic syndrome, its presence is associated with increased risk for cardiovascular disease. 8 Despres and 
Methods
Study design and recruitment of participants Recruitment to the PROCAM Study 10, 11 was started in 1979.
The basic study design has been described elsewhere. 12 We certify that all applicable Institutional and Governmental Regulations concerning the ethical use of human volunteers were followed during this research. The sample of 7134 men (35-65 years of age) used for the current evaluation represented a subcohort of the PROCAM Study recruited before 1999. The basic characteristics of the study population are shown in Table 1 . In all, 404 major coronary events occurred within 10 years of follow-up, enough to allow statistically valid longitudinal analysis. A total of 295 participants died from other causes, and 65 nonfatal cases of stroke occurred.
Risk algorithms
The PROCAM risk algorithm employed in this study was from the previously published Cox proportional hazards model. 12 The algorithm incorporates the following eight (Table 2) .
Results
The strong correlation that existed between BMI and waist circumference (r ¼ 0.87) in a representative subsample of the PROCAM cohort consisting of 4896 men suggested that BMI and waist circumference provided similar information ( Table 2) . We therefore developed the modified PROCAM risk algorithm by incorporating BMI as fixed variable in a multilogistic regression model along with 56 other clinical and laboratory variables measured in the PROCAM study. Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; MI, myocardial infarction; TG, triglyceride. 
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The following seven variables were found to be independently predictive of event risk and were used along with BMI to construct the risk algorithm based on a Cox proportional hazards model: age, LDL cholesterol, smoking, HDL cholesterol, pulse pressure, family history of premature myocardial infarction and diabetes mellitus ( Table 3) . The variables and their coefficients used in the construction of the 'classical' Cox proportional hazards model are shown for comparison in Table 4 . The observed cases of major coronary events within 10 years of follow-up in each of the five quintiles of estimated global risk calculated with the BMI-based Cox proportional hazards model for men are shown in Figure 1 . As is evident, individuals in the uppermost quintile of the global risk distribution were almost 50-fold more likely to be affected by a major coronary event compared with those in the lowest quintile. We also compared the performance of the BMI-based modified model with the previously established traditional PROCAM algorithm using receiver-operating characteristics (ROC) curve analysis ( Figure 2 ). Although the area under the ROC curve obtained by means of the conventional Cox function of 82.1% was marginally larger than the area under the ROC curve obtained with the modified Cox model (82.0%), the difference was not significant, indicating that the ability of both models to predict the relative risk of an acute coronary event was essentially equivalent. To evaluate the new BMI-based PROCAM risk algorithm with respect to its ability to predict coronary events in individuals with metabolic syndrome, we divided the study population into two groups with or without the metabolic syndrome at study entry. As shown in Figure 3 , 2325 men (32.6%) fulfilled the criteria of the metabolic syndrome. In all, 224 major coronary events occurred in this group within 10 years of follow-up (incidence rate: 9.6%). In the 4809 men not classified as having metabolic syndrome, 180 major coronary events were observed (incidence rate: 3.7%). Thus, men with metabolic syndrome were 2.59-fold more likely to experience a major coronary event within 10 years of followup than men not having the metabolic syndrome. Most importantly, the mean estimated risk based on the new modified PROCAM risk algorithm was 10.2% in the group with metabolic syndrome and 4.6% in the group without metabolic syndrome (Figure 3) , and thus closely resembled the observed event rates.
As shown in Figure 4 , the observed major coronary event incidence rates corresponded well with the expected rates according to the modified PROCAM risk algorithm over the entire global risk distribution range in both groups.
Discussion
Individuals with metabolic syndrome are characterized by the presence of a cluster of metabolic abnormalities, including central obesity, dyslipidaemia (elevated triglycerides, low HDL cholesterol and often also high LDL cholesterol), elevated blood pressure, and insulin resistance or glucose intolerance. Additional frequently observed anomalies include a prothrombotic state (that is, high fibrinogen or plasminogen activator inhibitor-1 in the blood) and/or a proinflammatory state (that is, elevated C-reactive protein in the blood). In practice, patients represent with a continuum of anomalies ranging from moderate overweight linked to moderately decreased HDL and mildly elevated blood pressure to full expression of the syndrome with presence of all its anomalies in a very significant manner. [14] [15] [16] [17] [18] It is conceivable that coronary risk depends importantly on this clinical variability and interaction with other coronary risk factors, which can best be accounted for by a validated risk algorithm that incorporates central obesity as one of the most significant features of the metabolic syndrome. Increased waist circumference is a measure for central obesity. We here show that waist circumference is strongly correlated with BMI in the PROCAM Study population. Therefore, we considered BMI and waist circumference as essentially exchangeable variables and used BMI as a predefined fixed variable in constructing the new PROCAM algorithm for assessing coronary event risk in the metabolic syndrome.
In comparison with the traditional fully adjusted PROCAM algorithm, pulse pressure came out as independent variable in the new modified BMI-based model with a similar coefficient and hazard ratio as systolic blood pressure in the traditional PROCAM algorithm. The fixed variable BMI provided similar information as triglycerides did in the conventional model. Minor differences with respect to the coefficients of all other risk factors (age, HDL and LDL cholesterol, diabetes, smoking status and family history of premature coronary heart disease) were not significant. As shown by ROC curve analysis, the diagnostic performance of the BMI-based modified model was essentially equal compared with the previously published fully adjusted PROCAM algorithm. 12 We show that men with metabolic syndrome according to the NCEP-ATP III definition were 2.59-fold more likely to On the basis of pathophysiological considerations, Despres and Lemieux 9 have recently introduced a concept of 'cardiometabolic risk'. They suggested that the presence of the metabolic syndrome should be considered separately from traditional risk factors in global risk assessment. On the basis of the observation that risk calculations performed with the Framingham algorithm tended to significantly underestimate the risk of myocardial infarction in individuals with the metabolic syndrome, it was argued that the syndrome may per se add excess risk to the global coronary heart disease risk estimates provided by established risk algorithms. Specifically, they proposed that the calculated risk scores should be doubled in individuals with the diagnosis of metabolic syndrome. 9 The results of our study argue against this concept and instead suggest that both PROCAM algorithms accurately predict risk of myocardial infarction in men with the metabolic syndrome. The origin of these discrepant observations is at present unclear. It should be noted, however, that the PROCAM algorithms incorporate different variables compared with the Framingham algorithm. Notably, triglycerides, BMI/waist circumference and family history of myocardial infarction, which are components of the PROCAM algorithms, are not considered by the Framingham algorithm. Another difference is that the Framingham algorithm incorporates total cholesterol, whereas the PROCAM algorithms incorporate LDL cholesterol. Thus, it is conceivable that the set of variables that is incorporated in the PROCAM algorithms may represent an improvement in risk ascertainment, especially in individuals with the metabolic syndrome.
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US has received consultancy fees from MSD and lecture fees from Pfizer. The other authors declared no financial interests. without metabolic syndrome with metabolic syndrome Figure 4 Major coronary event incidence rates and calculated risk. The observed (grey bars) and expected (hatched bars) coronary events in individuals without (left panel) and with (right panel) metabolic syndrome stratified according to low (o10% in 10 years), moderate (10-20% in 10 years) and high (420% in 10 years) global risk are shown. Note that observed major coronary event incidence rates correspond well with the expected rates according to the modified body mass indexbased PROCAM risk algorithm over the entire global risk distribution range in both groups. MI, myocardial infarction.
